St. David's HealthCare July 05, 2018

Accreditation by Foundation for the Accreditation of Cellular Therapy (FACT) awarded for adult allogeneic and autologous bone marrow transplants

AUSTIN, Texas – St. David’s South Austin Medical Center has received an internationally recognized accreditation in the field of cellular therapy transplantation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center. By demonstrating compliance with the FACT-JACIE (Joint Accreditation Committee-ISCT & EBMT) International Standards for Cellular Therapy Product Collection, Processing and Administration, the hospital has earned FACT Accreditation for adult allogeneic and autologous bone marrow transplants, as well as Immune Effector Cellular Therapy.

FACT, the accrediting body for hospitals and medical institutions offering stem cell transplants, awards the designation for the entire spectrum of stem cell therapy, including clinical care, donor management, cell collection, processing, storage, transportation, administration and cell release. This accreditation signifies the hospital has met the most rigorous standards in every aspect of stem cell therapy.

“We are dedicated to providing the most advanced cellular therapy treatments, and this recognition reflects our commitment to delivering exceptional care to patients with blood cancers,” Dr. Aravind Ramakrishnan, director of the adult bone marrow transplant program at St. David’s South Austin Medical Center, said. “We are pleased to have earned this accreditation.”

FACT-JACIE Standards, which are used to determine accreditation, are defined by leading experts based on the latest knowledge of the field of cellular therapy transplantation. Accreditation is attained through evaluation of submitted documentation and on-site inspection to determine if an organization is in compliance with current FACT standards and the United States Food and Drug Administration’s current rules for Good Tissue Practice.

-30-

St. David’s South Austin Medical Center

St. David’s South Austin Medical Center, which is part of St. David’s HealthCare, is a 300-bed acute care facility offering a range of complex specialties and sub-specialties, including a nationally accredited oncology program with the area’s only adult bone marrow transplant program; a trauma program that includes a Level II trauma center to treat the most severely injured and critical patients; a comprehensive cardiac program; full-service maternity and newborn care with Level I and II nurseries; and two full-service emergency centers in the communities of Bee Cave and Bastrop.

FACT

In December 1994, the International Society for Cellular Therapy (ISCT) and the American Society for Blood and Marrow Transplantation (ASBMT) merged their standards into a single document covering all aspects of hematopoietic cell therapy (collection, processing and transplantation). The two societies established FACT in order to develop a voluntary Inspection and Accreditation Program based on the joint Standards. FACT promotes quality medical and laboratory practice of cellular therapy through its peer-developed standards and voluntary inspection and accreditation program.

In 2006, FACT, in collaboration with the Joint Accreditation Committee–ISCT & EBMT (JACIE), developed international standards in the field of cellular therapy. JACIE was founded by the European Group for Blood and Marrow Transplantation (EBMT) and the International Society for Cellular Therapy (ISCT), the two leading scientific organizations involved with cellular transplantation in Europe.

Since 2007, FACT accreditation has been used in determining the U.S. News & World report rankings of transplant centers for the "America's Best Hospitals" and "America's Best Children's Hospitals" list.